Exact Sciences
EXAS
#1144
Rank
NZ$33.40 B
Marketcap
NZ$176.01
Share price
-0.15%
Change (1 day)
67.88%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -NZ$1.72 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$3.08 Billion. In 2024 the company made an earning of -NZ$1.76 Billion a decrease over its 2023 earnings that were of -NZ$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$1.72 Billion-2.3%
2024 -NZ$1.76 Billion435.05%
2023 -NZ$0.33 Billion-69.18%
2022 -NZ$1.07 Billion-25.77%
2021 -NZ$1.44 Billion1.68%
2020 -NZ$1.42 Billion271.17%
2019 -NZ$0.39 Billion58.99%
2018 -NZ$0.24 Billion20.89%
2017 -NZ$0.2 Billion-30.95%
2016 -NZ$0.29 Billion5.09%
2015 -NZ$0.28 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$80.2 Million
2011 -NZ$49.93 Million143.73%
2010 -NZ$20.49 Million27.85%
2009 -NZ$16.03 Million0.27%
2008 -NZ$15.98 Million-20.95%
2007 -NZ$20.22 Million-13.53%
2006 -NZ$23.38 Million-10.07%
2005 -NZ$26 Million-21.81%
2004 -NZ$33.25 Million-33.44%
2003 -NZ$49.96 Million-6.51%
2002 -NZ$53.43 Million17.95%
2001 -NZ$45.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Myriad Genetics
MYGN
-NZ$0.73 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.11 B-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
NZ$42.86 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$60.57 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.76 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France